Kevin Caldwell: As CEO, Co-Founder & President of Ossium Health, Kevin Caldwell has built Ossium from a small startup into a clinical-stage bioengineering company.  Kevin set the company’s mission to improve human health through bioengineering and designed its platform-based model for cellular therapeutics development. Before founding Ossium, Kevin served as an Engagement Manager at McKinsey’s San Francisco office, advising clients in the biotechnology and healthcare sectors. Mr. Caldwell led more than 20 engagements with more than a dozen clients, leading teams that advised clients on revenue growth, go-to-market strategy, and organizational restructuring. Before McKinsey, Kevin served as a Senior Investment Associate at Bridgewater Associates, where he did quantitative research for the firm’s global macro investments. A graduate of both MIT and Harvard, Mr. Caldwell studied Physics and Economics at MIT before receiving his JD from Harvard Law School. Mr. Caldwell is a member of the Young President’s Organization (YPO), and a Fellow of the Leaders in Tech Program.

Matt Ryll: Matt Ryll is the Associate Director of Recovery Services for Ossium Health. He focuses on training and onboarding, quality and process improvements, as well as general OPO and Tissue Partner relationships. Before joining Ossium, Matt worked at New England Donor Services, where he was a Tissue Recovery Manager and a Recovery Trainer. Matt received his bachelor’s at the University of Massachusetts, Amherst, and is CTBS as well as CEBT certified.